跳至主要内容
临床试验/IRCT20220111053694N1
IRCT20220111053694N1已完成2 期

Addition of a very low dose of naloxone to remifentanil infusion on postoperative pain in patients undergoing total hip replacement surgery

Mashhad University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • In this study, clinical trial of patients undergoing hip replacement surgery under general anesthesia
  • No contraindications for general anesthesia
  • No chronic pain
  • Between 18 and 65 years
  • With physical condition ASA I-II (scoring status Physical, American Society of Anesthesiologists)
  • Filled out a written informed consent form

排除标准

  • Obesity (BMI = 30 kg / m2 )
  • Pregnancy (based on B-HCG check)
  • Dependence on drugs and alcohol
  • Use of any painkillers in the last 24 hours
  • Unusual bleeding
  • Ischemic heart disease
  • History of seizures
  • Decrease or increase in blood pressure by more than 30% of baseline
  • Any surgical complications such as prosthetic fractures or enlargement of the surgery due to extensive fractures of the pelvis
  • Postoperative exclusion criteria include reoperation
  • Excessive bleeding
  • Long-term ventilation (> 12 hours)

研究者

相似试验